JP2024512497A5 - - Google Patents

Info

Publication number
JP2024512497A5
JP2024512497A5 JP2023557369A JP2023557369A JP2024512497A5 JP 2024512497 A5 JP2024512497 A5 JP 2024512497A5 JP 2023557369 A JP2023557369 A JP 2023557369A JP 2023557369 A JP2023557369 A JP 2023557369A JP 2024512497 A5 JP2024512497 A5 JP 2024512497A5
Authority
JP
Japan
Application number
JP2023557369A
Other languages
Japanese (ja)
Other versions
JP2024512497A (ja
JPWO2022197763A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/020491 external-priority patent/WO2022197763A1/en
Publication of JP2024512497A publication Critical patent/JP2024512497A/ja
Publication of JP2024512497A5 publication Critical patent/JP2024512497A5/ja
Publication of JPWO2022197763A5 publication Critical patent/JPWO2022197763A5/ja
Pending legal-status Critical Current

Links

JP2023557369A 2021-03-17 2022-03-16 血漿カリクレインの阻害剤 Pending JP2024512497A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163162487P 2021-03-17 2021-03-17
US63/162,487 2021-03-17
PCT/US2022/020491 WO2022197763A1 (en) 2021-03-17 2022-03-16 Inhibitors of plasma kallikrein

Publications (3)

Publication Number Publication Date
JP2024512497A JP2024512497A (ja) 2024-03-19
JP2024512497A5 true JP2024512497A5 (https=) 2025-03-24
JPWO2022197763A5 JPWO2022197763A5 (https=) 2025-03-24

Family

ID=81326196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557369A Pending JP2024512497A (ja) 2021-03-17 2022-03-16 血漿カリクレインの阻害剤

Country Status (5)

Country Link
US (1) US20240226106A1 (https=)
EP (1) EP4308229A1 (https=)
JP (1) JP2024512497A (https=)
CN (1) CN117396469A (https=)
WO (1) WO2022197763A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200143376A (ko) 2018-03-13 2020-12-23 샤이어 휴먼 지네틱 테라피즈 인크. 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도
CN114667289B (zh) 2019-09-18 2025-08-26 武田药品工业有限公司 杂芳基血浆激肽释放酶抑制剂
EP4031547B1 (en) 2019-09-18 2024-07-17 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
ATE141502T1 (de) 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
CA2385747A1 (en) * 1999-09-17 2001-03-22 Gavin C. Hirst Pyrazolopyrimidines as therapeutic agents
IL156315A0 (en) * 2000-12-07 2004-01-04 Cv Therapeutics Inc Abca-1 elevating compounds
AR077033A1 (es) * 2009-06-11 2011-07-27 Hoffmann La Roche Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
WO2014074715A1 (en) * 2012-11-07 2014-05-15 Genentech, Inc. Cyclopropyl amide derivatives
CN105849097A (zh) * 2013-11-06 2016-08-10 百时美施贵宝公司 取代的吡啶衍生物用作gsk-3抑制剂
WO2015164308A1 (en) * 2014-04-22 2015-10-29 Merck Sharp & Dohme Corp. FACTOR XIa INHIBITORS
AU2016247768B2 (en) * 2015-04-17 2019-03-07 Corteva Agriscience Llc Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
US10287288B2 (en) * 2015-07-29 2019-05-14 Bristol-Myers Squibb Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties
RU2019133646A (ru) * 2017-03-30 2021-04-30 Ф. Хоффманн-Ля Рош Аг Изохинолины в качестве ингибиторов hpk1
MX2019011511A (es) * 2017-03-30 2019-11-18 Hoffmann La Roche Naftiridinas como inhibidores de cinasa 1 progenitora hematopoyetica (hpk1).
MX2020005210A (es) * 2017-11-21 2020-08-20 Bristol Myers Squibb Co Compuestos de heteroarilo sustituidos con alquilamida de piridinsulfona.
KR20200143376A (ko) 2018-03-13 2020-12-23 샤이어 휴먼 지네틱 테라피즈 인크. 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도
TW202116753A (zh) * 2019-07-11 2021-05-01 大陸商南京征祥醫藥有限公司 以噌啉作為hpk1的抑制劑
CN114516867B (zh) * 2020-04-28 2023-09-15 江南大学 一类含氧五元杂环化合物、合成方法、药物组合物及用途

Similar Documents

Publication Publication Date Title
JP2024512497A5 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BY13172U (https=)
CN307045453S (https=)
CN307047945S (https=)
CN307047404S (https=)
CN307047375S (https=)
CN307047206S (https=)
CN307047183S (https=)
CN307047000S (https=)
CN307046285S (https=)
CN307046148S (https=)
CN307046137S (https=)
CN307045947S (https=)
BY13168U (https=)
CN307044912S (https=)
CN307044327S (https=)
CN307044309S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13169U (https=)
BY13170U (https=)